Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Choroidal Futures of Eyes with Circumscribed Choroidal Hemangioma in Ultra Wide-Field Optical Coherence Tomography Angiography
Author Affiliations & Notes
  • Judith Kreminger
    Vienna Clinical Trial Center, Department of Ophthalmology and Optometry, Medizinische Universitat Wien, Wien, Wien, Austria
  • Stephanie Rokitansky
    Vienna Clinical Trial Center, Department of Ophthalmology and Optometry, Medizinische Universitat Wien, Wien, Wien, Austria
  • Adrian Reumueller
    Department of Ophthalmology and Optometry, Medizinische Universitat Wien, Wien, Wien, Austria
  • Reinhard Told
    Department of Ophthalmology and Optometry, Medizinische Universitat Wien, Wien, Wien, Austria
  • Roman Dunavoelgyi
    Department of Ophthalmology and Optometry, Medizinische Universitat Wien, Wien, Wien, Austria
  • Ursula Schmidt-Erfurth
    Department of Ophthalmology and Optometry, Medizinische Universitat Wien, Wien, Wien, Austria
  • Stefan Sacu
    Vienna Clinical Trial Center, Department of Ophthalmology and Optometry, Medizinische Universitat Wien, Wien, Wien, Austria
    Department of Ophthalmology and Optometry, Medizinische Universitat Wien, Wien, Wien, Austria
  • Footnotes
    Commercial Relationships   Judith Kreminger None; Stephanie Rokitansky None; Adrian Reumueller None; Reinhard Told None; Roman Dunavoelgyi None; Ursula Schmidt-Erfurth Appells, Code C (Consultant/Contractor), Genetech,Kodiak,Novartis,Apellis,RetInSight, Code F (Financial Support), RetInSight, Code P (Patent); Stefan Sacu Roch,Bayer,Iveric,Ionis, Code C (Consultant/Contractor), Roche,Bayer,Iveric,Ionis, Code F (Financial Support)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3431. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Judith Kreminger, Stephanie Rokitansky, Adrian Reumueller, Reinhard Told, Roman Dunavoelgyi, Ursula Schmidt-Erfurth, Stefan Sacu; Choroidal Futures of Eyes with Circumscribed Choroidal Hemangioma in Ultra Wide-Field Optical Coherence Tomography Angiography. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3431.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A recent innovation in OCT-Angiography (OCTA) provides images with enhanced imaging depth of 12mm on an extended field of view of 21mmx26mm, allowing a precise assessment of choroidal vascular alterations. This study aims to evaluate the ultra wide-field choroidal and vascular findings in eyes with circumscribed choroidal hemangioma (CCH) as depicted by the Dream-OCT (Intalight, Shanghai, China).

Methods : Consecutive patients with CCH were included in this cross-sectional case-study at the Department of Ophthalmology and Optometry, Medical University of Vienna. The diagnosis was previously confirmed with echo- and angiography. Full ophthalmic examination, best-corrected visual acuity (BCVA) and a ultra wide-field (UWF) OCTA were performed. Choroidal vascularity index (CVI), central retinal thickness (CRT) and choroidal thickness (CT) were assessed on study eyes (SE) and healthy fellow eyes (FE) using the software of the OCTA device. Measurement of CT excluded the area of CCH.

Results : Nine patients (female n=3 (33.3%); median age=68 years (interquartile range (IQR) 23.5 years)) were included in the study. Median duration of disease was 44 months (IQR 81 months) and median BCVA (logMAR) was 0.3 (IQR 1.0). In UWF-OCTA median area of CCH was 26.0mm2 (IQR 27.3mm2). In sonography median largest basal diameter, smallest basal diameter and thickness were 8.3mm (IQR 3.6mm), 6.0mm (IQR 3.4mm) and 2.7mm (IQR 1.1mm), respectively. CVI was significantly lower in SE (median 0.40 (IQR 0.07) vs 0.43 (IQR 0.07); Wilcoxon-Test p=0.008), while CT was significantly higher in SE (median 315μm (IQR 91μm) vs 259μm (IQR 54μm), Wilcoxon-Test p=0.022). Despite 6 patients (66.7%) presented with intra- and/or subretinal fluid proximal to CCH, there was no difference in CRT (median 313μm (IQR 155μm) vs 307μm (IQR 44μm), Wilcoxon-Test p=0.066), as fluid was sometimes localized in the periphery proximal to CCH.

Conclusions : CCH could be precisely detected in WF-OCTA with increased depth. CT is higher and CVI is lower in SE as compared to FE.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

62-year-old male patient with pretreated CCH. A: Display of automatically annotated choroidal vessels for the calculation of CVI. Red arrows indicate CCH with different vessel pattern. Green line indicates location of image B. B: B-Scan of CCH with enhanced depth imaging.

62-year-old male patient with pretreated CCH. A: Display of automatically annotated choroidal vessels for the calculation of CVI. Red arrows indicate CCH with different vessel pattern. Green line indicates location of image B. B: B-Scan of CCH with enhanced depth imaging.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×